Investments
112Portfolio Exits
22Funds
7Expert Collections containing The Column Group
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find The Column Group in 1 Expert Collection, including CB Insights Healthcare Smart Money Investors - 2020.
CB Insights Healthcare Smart Money Investors - 2020
25 items
Track the world's top-performing VC investors in healthcare. Firms are presented in alphabetical order.
The Column Group Web Traffic
The Column Group Rank
Research containing The Column Group
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned The Column Group in 4 CB Insights research briefs, most recently on Feb 16, 2021.
Latest The Column Group News
May 16, 2022
NGM Biopharmaceuticals (NASDAQ: NGM ) stock climbed as much as 10.2% on Monday after the firm disclosed certain insider buying . NGM disclosed that director and 10% owner Column Group bought ~166.4K shares at $10.73-$11.99 worth ~$1.9M in multiple transactions. Column Group now holds ~11.1M shares in NGM. Take a look at NGM's ownership structure: NGM stock has fallen ~30% YTD. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
The Column Group Investments
112 Investments
The Column Group has made 112 investments. Their latest investment was in Remix Therapeutics as part of their Series B on May 5, 2022.
The Column Group Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/17/2022 | Series B | Remix Therapeutics | $70M | No | 5 | |
2/23/2022 | Series B | Plexium | $102M | No | 9 | |
2/15/2022 | Series D | Kallyope | $236M | No | 20 | |
1/6/2022 | Series B | |||||
9/9/2021 | Series B |
Date | 5/17/2022 | 2/23/2022 | 2/15/2022 | 1/6/2022 | 9/9/2021 |
|---|---|---|---|---|---|
Round | Series B | Series B | Series D | Series B | Series B |
Company | Remix Therapeutics | Plexium | Kallyope | ||
Amount | $70M | $102M | $236M | ||
New? | No | No | No | ||
Co-Investors | |||||
Sources | 5 | 9 | 20 |
The Column Group Portfolio Exits
22 Portfolio Exits
The Column Group has 22 portfolio exits. Their latest portfolio exit was Entrada Therapeutics on October 29, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
10/29/2021 | IPO | Public | 7 | ||
7/30/2021 | IPO | Public | 4 | ||
5/27/2021 | Acq - Pending | 2 | |||
Date | 10/29/2021 | 7/30/2021 | 5/27/2021 | ||
|---|---|---|---|---|---|
Exit | IPO | IPO | Acq - Pending | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | Public | |||
Sources | 7 | 4 | 2 |
The Column Group Fund History
7 Fund Histories
The Column Group has 7 funds, including PONOI CAPITAL.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
12/31/2017 | PONOI CAPITAL | Early-Stage Venture Capital | Closed | 1 | |
4/27/2016 | Column Group III | ||||
4/27/2016 | Column Group III-A | ||||
9/16/2014 | Column Group II | ||||
4/30/2008 | Column Group LP |
Closing Date | 12/31/2017 | 4/27/2016 | 4/27/2016 | 9/16/2014 | 4/30/2008 |
|---|---|---|---|---|---|
Fund | PONOI CAPITAL | Column Group III | Column Group III-A | Column Group II | Column Group LP |
Fund Type | Early-Stage Venture Capital | ||||
Status | Closed | ||||
Amount | |||||
Sources | 1 |
The Column Group Team
7 Team Members
The Column Group has 7 team members, including current Managing Partner, David V. Goeddel.
Name | Work History | Title | Status |
|---|---|---|---|
David V. Goeddel | Managing Partner | Current | |
Tim Kutzkey | Managing Partner | Current | |
Peter H. Svennilson | Three Crowns Capital, and Nomura Holdings | Managing Partner | Current |
Jeffrey Baxter | Managing Partner | Former | |
Harald Ekman | Three Crowns Capital, Goldman Sachs, and Nomura Holdings | Managing Partner | Former |
Name | David V. Goeddel | Tim Kutzkey | Peter H. Svennilson | Jeffrey Baxter | Harald Ekman |
|---|---|---|---|---|---|
Work History | Three Crowns Capital, and Nomura Holdings | Three Crowns Capital, Goldman Sachs, and Nomura Holdings | |||
Title | Managing Partner | Managing Partner | Managing Partner | Managing Partner | Managing Partner |
Status | Current | Current | Current | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.